1 to 10 of 74 trials

• Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells

  conditions:	Multiple Sclerosis
  interventions:	INFNb-1b
  last updated:	2009 Jun 23
  status:	recruiting
  sponsor:	The University of North Carolina, Chapel Hill

   

• Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients

  conditions:	Melanoma
  interventions:	autologous dendritic cell vaccination
  last updated:	2009 Jul 14
  status:	recruiting
  sponsor:	Radboud University

   

• Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

  conditions:	Autoimmune Disease ; Lymphatic Disease ; Lymphoproliferative Disorder ; Canale-Smith Syndrome
  interventions:	none
  last updated:	2008 Oct 21
  status:	recruiting
  sponsor:	National Institute of Allergy and Infectious Diseases (NIAID)

   

• Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route

  conditions:	Healthy Volunteers ; HIV Infection
  interventions:	Transcutaneous mode of administration
  last updated:	2006 Apr 18
  status:	terminated
  sponsor:	Objectif Recherche Vaccins SIDA

   

• Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas

  conditions:	Peripheral T-Cell Lymphomas ; Non-Hodgkin Lymphoma
  interventions:	Velcade
  last updated:	2006 Dec 7
  status:	recruiting
  sponsor:	Samsung Medical Center

   

• Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

  conditions:	Chronic Myeloproliferative Disorders ; Leukemia ; Lymphoma ; Multiple Myeloma and Plasma Cell Neoplasm ; Myelodysplastic Syndromes ; Myelodysplastic/Myeloproliferative Diseases
  interventions:	rituximab ; busulfan ; carmustine ; cyclophosphamide ; cytarabine ; etoposide ; fludarabine phosphate ; melphalan ; total-body irradiation
  last updated:	2009 Feb 6
  status:	not yet recruiting
  sponsor:	Barbara Ann Karmanos Cancer Institute

   

• Tai-Chi-Chuan on Differentiation and Maturation of Dendritic Cells

  conditions:	Immunity
  interventions:	none
  last updated:	2008 Sep 19
  status:	completed
  sponsor:	Mackay Memorial Hospital

   

• Effect of Thiazolidinediones on Human Bone

  conditions:	Osteoblast ; Adipocytes ; Bone Density ; Osteocalcin ; Adiponectin ; Mesenchymal Stem Cells
  interventions:	Pioglitazone or placebo
  last updated:	2009 Jun 24
  status:	recruiting
  sponsor:	Emory University

   

• T Cell Cytokine Changes During IL-4 Receptor Treatment for Asthma

  conditions:	Asthma ; Hypersensitivity
  interventions:	none
  last updated:	2008 Mar 3
  status:	completed
  sponsor:	National Institute of Allergy and Infectious Diseases (NIAID)

   

• Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy

  conditions:	Melanoma
  interventions:	dendritic cell vaccine
  last updated:	2008 Jun 17
  status:	active, not recruiting
  sponsor:	Memorial Sloan-Kettering Cancer Center